pI: 7.8615 |
Length (AA): 164 |
MW (Da): 19205 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 156 | 1jke (A) | 1 | 144 | 32.00 | 0 | 1 | 1.44 | -1.57 |
1 | 160 | 2dbo (A) | 1 | 148 | 43.00 | 0 | 1 | 1.55 | -1.34 |
1 | 163 | 4nbi (A) | 1 | 163 | 99.99 | 0 | 1 | 2.2774 | -1.93 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, Male Gametocyte. | Otto TD Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 32 hs, intra-erythrocytic - 48 hs, Oocyst, Ring, Female Gametocyte. | Otto TD Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 40 hs, late ring, Sporozoite. | Otto TD PlasmoDB Zanghi G |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Ortholog group members (OG5_127541)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G18460 | D-Tyr-tRNA(Tyr) deacylase family protein |
Brugia malayi | Bm1_04600 | D-tyrosyl-tRNA(Tyr) deacylase |
Candida albicans | CaO19.297 | D-Tyr-tRNA[Tyr] deacylase |
Candida albicans | CaO19.7911 | D-Tyr-tRNA[Tyr] deacylase |
Candida albicans | CaO19.7929 | D-Tyr-tRNA[Tyr] deacylase |
Candida albicans | CaO19.279 | D-Tyr-tRNA[Tyr] deacylase |
Caenorhabditis elegans | CELE_T16G1.10 | Protein PQN-68, isoform A |
Cryptosporidium hominis | Chro.70583 | RNA helicase-like protein |
Cryptosporidium parvum | cgd7_5230 | possible D-Tyr-tRNatyr deacylase |
Dictyostelium discoideum | DDB_G0291273 | D-tyrosyl-tRNA deacylase |
Drosophila melanogaster | Dmel_CG18643 | CG18643 gene product from transcript CG18643-RC |
Escherichia coli | b3887 | D-tyr-tRNA(Tyr) deacylase |
Echinococcus granulosus | EgrG_000767800 | hypothetical protein |
Echinococcus granulosus | EgrG_000767700 | D tyrosyl tRNATyr deacylase |
Entamoeba histolytica | EHI_118150 | D-tyrosyl-tRNA(Tyr) deacylase, putative |
Echinococcus multilocularis | EmuJ_000767700 | D tyrosyl tRNA(Tyr) deacylase |
Echinococcus multilocularis | EmuJ_000767800 | conserved hypothetical protein |
Giardia lamblia | GL50803_13832 | D-tyrosyl-tRNA deacylase |
Homo sapiens | ENSG00000125821 | D-tyrosyl-tRNA deacylase 1 |
Leishmania braziliensis | LbrM.35.2950 | D-tyrosyl-tRNA deacylase, putative |
Leishmania donovani | LdBPK_362870.1 | D-tyrosyl-tRNA deacylase, putative |
Leishmania infantum | LinJ.36.2870 | D-tyrosyl-tRNA deacylase, putative |
Leishmania major | LmjF.36.2730 | D-tyrosyl-tRNA deacylase, putative |
Leishmania mexicana | LmxM.36.2730 | D-tyrosyl-tRNA deacylase, putative |
Loa Loa (eye worm) | LOAG_06351 | D-tyrosyl-tRNA deacylase |
Mus musculus | ENSMUSG00000027430 | D-tyrosyl-tRNA deacylase 1 |
Mycobacterium tuberculosis | Rv1897c | Conserved hypothetical protein |
Mycobacterium ulcerans | MUL_2960 | D-tyrosyl-tRNA(Tyr) deacylase |
Neospora caninum | NCLIV_061570 | D-tyrosyl-tRNA(Tyr) deacylase (EC 3.1.-.-), related |
Oryza sativa | 4327697 | Os01g0242500 |
Plasmodium berghei | PBANKA_0938700 | D-tyrosyl-tRNA(Tyr) deacylase, putative |
Plasmodium falciparum | PF3D7_1108200 | D-tyrosyl-tRNA(Tyr) deacylase |
Plasmodium knowlesi | PKNH_0905800 | D-tyrosyl-tRNA(Tyr) deacylase, putative |
Plasmodium vivax | PVX_091090 | D-tyrosyl-tRNA(Tyr) deacylase, putative |
Plasmodium yoelii | PY00917 | predicted using Genefinder |
Saccharomyces cerevisiae | YDL219W | Dtd1p |
Schistosoma japonicum | Sjp_0040420 | ko:K01175 DTD1, C20orf88, HARS2; D-tyrosyl-tRNA deacylase 1 homolog [EC:3.1.-.-], putative |
Schistosoma mansoni | Smp_146570 | histidyl-tRNA synthetase-related |
Schmidtea mediterranea | mk4.003187.01 | D-tyrosyl-tRNA(Tyr) deacylase 1 |
Trypanosoma brucei gambiense | Tbg972.10.8810 | D-tyrosyl-tRNA deacylase, putative |
Trypanosoma brucei | Tb927.10.7190 | D-tyrosyl-tRNA deacylase, putative |
Trypanosoma congolense | TcIL3000_10_6170 | D-tyrosyl-tRNA deacylase, putative |
Toxoplasma gondii | TGME49_218810 | histidyl-tRNA synthetase |
Trichomonas vaginalis | TVAG_010100 | D-tyrosyl-tRNA(tyr) deacylase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.7190 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.7190 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.7190 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.7190 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b3887 | Escherichia coli | non-essential | goodall |
TGME49_218810 | Toxoplasma gondii | Probably non-essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.2